Long-term Cognitive, Neuropsychiatric and Functional Outcomes in Adults Who Have Received Chimeric Antigen-Receptor T-Cell (CAR-T) Therapy for Aggressive Lymphoma at Stanford
Clinical trial NCT05416554 · WITHDRAWN
Trial details
- NCT number
- NCT05416554
- Sponsor
- Stanford University
- Status
- WITHDRAWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-01
- Primary completion
- 2026-12-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.